Cataract Clinical Trial
Official title:
Fellow Eye Study Evaluating Correlation Between Sulcus Anatomy and Ocular Parameters Using Ultrasound Biomicroscopy (UBM) After Horizontal or Vertical Placement of the Intraocular Lens (IOLs) in the Capsular Bag
Usually following cataract surgery patients would expect to have normal distance vision and not require the use of distance glasses. However, in clinical practice desired vision post cataract surgery is not achieved sometimes. In such cases a piggyback lens is used to enhance the visual outcome. This lens is placed in the ciliary sulcus (space between the iris and the lens). Often this piggyback lens is not the best fit for the ciliary sulcus space and it moves. This study will be using ultrasound biomicroscopy to measure the ciliary sulcus dimensions pre and postoperatively to estimate the normal anatomy and it's variations. Patients in this study will be randomised as to which way the intraocular lens is placed in the eye (horizontally or vertically) at the time of their cataract surgery. Patients requiring cataract surgery in both eyes will be identified from the Eye Hospital at the Royal Sussex County Hospital. Patients will be in the study for up to 6 months from being identified as suitable through to the operation in the 2nd eye and a final study visit.
Study Design This is a prospective, fellow eye randomised study.
Recruitment
A sample size of 92 eyes (46 patients) was calculated. Patients will be recruited at the
Sussex Eye Hospital preoperative cataract assessment clinics where they will be screened and
given a patient information sheet by a member of the research team if they can be recruited.
They will be allowed to take this home to discuss with their family/friends and/or GP. They
will be asked if the research team could contact them in a weeks time to discuss the study
and the plan for the day of their surgery (which is their next NHS visit). Patients can then
agree or decline to participate in the study . If they decline, their normal NHS pathway will
continue. If they accept, written informed consent will be taken on the day of surgery as
well as any extra imaging required. The key points of the trial will be reiterated and the
patient will be invited to ask any questions. All members of the research team are NIHR GCP
trained. All research patients will undergo surgery by the same surgeon and attend for
post-operative follow-up at the Sussex Eye Hospital. In addition at this visit a research
appointment will be made to undertake the research scans and examinations (see details below)
by an experienced member of our research team. The research team including the surgeon cannot
be blinded as the obvious direction of placement of the intraocular lens will be visible
during surgery and during examination.
Pre-operative appointment
Consent If the patient would like to participate they will be asked to read and sign a
consent form. If the patient gives consent for their GP to be notified of their participation
in the study a letter will be sent to the GP.
Standard pre-operative protocol for all NHS patients:
1. Unaided and best corrected distance visual acuity
2. Intraocular pressure measurement (applanation tonometry)
3. Optical or ultrasound biometry for lens power calculation
4. Slit lamp examination of the eye (by a doctor) including dilated fundus evaluation For
non-standard (research) measurements, patients will be asked to return for a separate
appointment. All measurements will be performed at ambient room light (undilated pupil).
The assessment will continue as follows:
1. Scheimpflug scans (Pentacam)
2. Anaesthesia of the eye with proxymetacaine 1%
3. Measurement using digital calipers of the white-to-white diameter Carbomer gel will be
applied to protect the cornea before application of ultrasound probe
4. Contact ultrasound biomicroscopy images will be taken in 4 axes: vertical, horizontal,
temporal oblique and nasal oblique. The patient will be asked to fixate with the fellow
eye on a target to maintain fixation and avoid accommodation. The examination will be
performed with undilated pupils.
Surgery
All surgery will be carried out by the same surgeon (Principal Investigator) who is an
experienced senior Ophthalmic Surgeon. This is to avoid any surgery-induced study biases.
Surgery will be performed employing a standardized technique with aspheric monofocal
intraocular lenses. The eyes will be randomized (1:1) using a dedicated computer programme
prior to the start of the study to have a vertical or horizontal placement of the intraocular
lens in the capsular bag. The 0 and 180 degrees will be marked on the slit lamp prior to the
surgery. The axes of the IOL will be orientated in reference to the midpoint of the optic
haptic junction of the IOL.
Non-standard (research)intervention post-operatively on the day of surgery:
Image taken with anterior segment ocular coherence tomography.
Standard post-operative protocol for all NHS patients at 4-6 weeks:
1) Unaided and best corrected distance visual acuity 2) Intraocular pressure measurement
(applanation tonometry) 3) Slit lamp examination of the eye Non-standard (research)
post-operative measurements for patients enrolled in this study (performed at the time
convenient to patient and the research team): All measurements will be performed at ambient
room light (undilated pupil).
1. Dilated retroillumination images of the IOL immediately postoperatively (ideally on the
day of the surgery)
2. Scheimpflug scans (Pentacam®) at 4-6 weeks
3. Anaesthesia of the eye with proxymetacaine 1% at 4-6 weeks
4. Carbomer gel will be applied to protect the cornea before application of ultrasound
probe. The patient will be asked to fixate with the fellow eye on a target to maintain
fixation and avoid accommodation. This examination performed with undilated pupils at
4-6 weeks.
5. Contact ultrasound biomicroscopy images at 4-6 weeks will be taken in 4 axes: vertical,
horizontal, temporal oblique and nasal oblique.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04685538 -
Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification.
|
Phase 3 | |
Recruiting |
NCT06060041 -
IC-8 Apthera IOL New Enrollment Post Approval Study
|
||
Recruiting |
NCT05518539 -
Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
|
||
Recruiting |
NCT05271942 -
Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods
|
N/A | |
Active, not recruiting |
NCT04778501 -
PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia
|
N/A | |
Completed |
NCT05062564 -
Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye
|
N/A | |
Completed |
NCT03751033 -
Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings
|
N/A | |
Completed |
NCT02529488 -
Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00
|
N/A | |
Completed |
NCT04539548 -
A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract
|
Phase 3 | |
Completed |
NCT03740659 -
Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery
|
Phase 2 | |
Completed |
NCT03494257 -
Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification
|
N/A | |
Completed |
NCT05119127 -
Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome.
|
N/A | |
Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
Recruiting |
NCT03713268 -
Intraoperative OCT Guidance of Intraocular Surgery II
|
||
Completed |
NCT03739528 -
Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery
|
Phase 3 | |
Completed |
NCT02888210 -
A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery
|
Phase 3 | |
Completed |
NCT03356847 -
Evaluation of the Rotational Stability of the Monofocal SISA Implant Following Cataract Surgery
|
N/A | |
Completed |
NCT04332640 -
Clinical Evaluation of the Next Generation Phaco System
|
N/A | |
Recruiting |
NCT03638726 -
Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification
|
Phase 4 | |
Completed |
NCT03050697 -
Evaluation of the Safety and Performance of the HARMONI® Toric Lens
|
N/A |